Noticias de ARDX_US
Noticias del mercado
Últimas noticias sobre ARDX_US — 546 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Over the last 7 days, the United States market has experienced a 1.6% decline, yet it remains up by 12% over the past year with earnings forecasted to grow by 17% annually. In such a dynamic environment, identifying high growth tech stocks involves looking for companies that demonstrate robust innovation and adaptability to capitalize on future opportunities.
Ardelyx (ARDX) is heading into a busy week with back to back investor appearances, including Citigroup’s Biopharma Back to School Summit on September 9 and Cantor Fitzgerald’s Global Healthcare Conference on September 10. Against this backdrop of conferences, Ardelyx’s recent trading has been weak. The share price is at $3.58 after declining 9.82% over the past 30 days and 37.08% over 90 days, while the 1-year total shareholder return is down 45.84%, compared with a 5-year total shareholder...
Ardelyx (ARDX) has come under closer investor scrutiny after recent share price pressure, with the stock down about 24% over the past month and roughly 31% over the past 3 months. At a latest share price of US$3.76, Ardelyx has moved sharply lower in recent months, with the 30 day share price return down 24% and the year to date share price return down 38.9%, while the 5 year total shareholder return remains positive at 168.6%. Broaden your watchlist beyond Ardelyx by scanning hand picked...
Página 16 de 28